News & events

News article 8 Feb 2017 IVCC secure licence with Indian manufacturer for production of IQKs developed at LSTM From: LSTM IVCC has signed a licence agreement with Tagros Chemicals India to manufacture and commercialise Insecticide Quantification Kits (IQKs) in India, and...
News article 18 Jan 2017 Centre of Excellence in Infectious Diseases Research launched From: LSTM LSTM and the University of Liverpool have launched a new joint centre which aims to address the urgent need to develop new antimicrobials and...
News article 29 Nov 2016 LSTM project receives a special mention in Access to Medicines Index 2016 From: LSTM LSTM’s partnership with pharmaceutical giant GSK looking at the capacity of key African institutions to undertake research into non-communicable...
News article 25 Nov 2016 LSTM’s 117th Annual General Meeting From: LSTM LSTM’s 117th Annual General Meeting (AGM) has taken place. The meeting saw LSTM’s vice-presidents, the Board of Trustees and Members along with staff...
News article 24 Nov 2016 Seminar Series Report: Systematic reviews of diagnostic test accuracy in infectious diseases. From: LSTM LSTM’s Seminar Series continued this week with a talk from Dr Mariska Leeflang from the Department of Clinical Epidemiology, Biostatistics and...
News article 23 Nov 2016 Seminar report: Mechanistic understanding to enable multi-targeting anti-infectives. From: LSTM LSTM hosted a special seminar this week as Professor Christopher Dowson and Dr David Roper from the University of Warwick gave a talk entitled:...
News article 23 Nov 2016 LSTM’s Clinical Diagnostic Parasitology Laboratory (CDPL) receives UKAS accreditation From: LSTM LSTM’s Clinical Diagnostic Parasitology Laboratory (CDPL) has recently undergone its first assessment by the United Kingdom Accreditation Service (...
News article 15 Nov 2016 New drug candidate for the curative treatment of onchocerciasis and lymphatic filariasis From: LSTM The LSTM based A-WOL consortium discovered the molecule TylAMac™ , which has been selected as a candidate for development as the first drug designed...